Jennifer Leonida
Family · Mt Pleasant, PANPI 1003189093
Payments from drug & device makers
Across 128 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$549
- AbbVie$441
- AstraZeneca$197
- Vanda Pharmaceuticals Inc.$182
- Lilly USA, LLC$153
- Abbott$138
- plus $692 from 21 others
What the payments were for
- Food & beverage$2,28697%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $549 |
| AbbVie | 24 | $441 |
| AstraZeneca | 12 | $197 |
| Vanda Pharmaceuticals Inc. | 4 | $182 |
| Lilly USA, LLC | 9 | $153 |
| Abbott | 7 | $138 |
| Pfizer | 7 | $107 |
| Boehringer Ingelheim | 6 | $96 |
| Astellas Pharma US Inc | 2 | $84 |
| GSK | 4 | $56 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $38 |
| Amgen | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Dexcom, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| VBI Vaccine (delaware) Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Bayer | 1 | $12 |
| Theracosbio, LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fanapt$125
How this compares
$2,352 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 38 | $38,862 |
| OzempicSemaglutide | 21 | $33,162 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $19,333 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $15,863 |
| VraylarCariprazine Hcl | 11 | $15,654 |
| TradjentaLinagliptin | 16 | $12,114 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $9,879 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $9,853 |
| Ventolin HfaAlbuterol Sulfate | 28 | $2,486 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,771 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,428 |
| Atorvastatin Calcium | 110 | $1,401 |
| Fenofibrate | 17 | $1,296 |
| Solifenacin Succinate | 17 | $1,288 |
| Potassium Chloride | 58 | $1,165 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $96 | $50,97654 claims |
| GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta | $56 | $45,07547 claims |
| Novo NordiskOzempic | $549 | $33,16221 claims |
| AbbVieVraylar | $441 | $15,65411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Mt Pleasant
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.